UroGen Pharma urogen.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The lead drug candidates, MitoGel and VesiGel, are designed to potentially remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade bladder cancer and low-grade upper tract urothelial carcinoma, or UTUC. In ad...Show all

UroGen Pharma (NASDAQ: URGN), fka Theracoat, is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies with a focus on uro-oncology. The lead drug candidates...Show all

Company (IPO / Went public)

Phone: +972-9-7707600

Fax:

9 Ha’Ta’asiya St

Ra'anana, 4365007
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
UroGen Pharma $65.2M May 4, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related UroGen Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Material and method for treating internal cavities Dec 01, 2016 Apr 24, 2018 Patent
Methods for treatment of bladder cancer Apr 10, 2015 Feb 06, 2018 Patent
Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer Jan 20, 2015 Oct 31, 2017 Patent
Phospholipid drug analogs Sep 29, 2015 Jan 10, 2017 Patent
Material and method for treating internal cavities Jul 19, 2012 May 26, 2015 Patent
See all 14 patents